z-logo
open-access-imgOpen Access
ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses
Author(s) -
AnnaMaria Herzner,
Zia Khan,
Eric L. Van Nostrand,
Sara M. Chan,
Trinna Cuellar,
Ronald Chen,
Ximo Pechuan-Jorge,
László G. Kömüves,
Margaret Solon,
Zora Modrušan,
Benjamin Haley,
G Yeo,
Timothy W. Behrens,
Matthew L. Albert
Publication year - 2021
Publication title -
the journal of experimental medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.483
H-Index - 448
eISSN - 1540-9538
pISSN - 0022-1007
DOI - 10.1084/jem.20201833
Subject(s) - adar , mda5 , rna silencing , rna editing , biology , alu element , rna , endogeny , rna binding protein , transcriptome , microbiology and biotechnology , genetics , rna interference , biochemistry , gene expression , gene , genome , human genome
Cytosolic double-stranded RNA (dsRNA) initiates type I IFN responses. Endogenous retroelements, notably Alu elements, constitute a source of dsRNA. Adenosine-to-inosine (A-to-I) editing by ADAR induces mismatches in dsRNA and prevents recognition by MDA5 and autoinflammation. To identify additional endogenous dsRNA checkpoints, we conducted a candidate screen in THP-1 monocytes and found that hnRNPC and ADAR deficiency resulted in synergistic induction of MDA5-dependent IFN responses. RNA-seq analysis demonstrated dysregulation of Alu-containing introns in hnRNPC-deficient cells via utilization of unmasked cryptic splice sites, including introns containing ADAR-dependent A-to-I editing clusters. These putative MDA5 ligands showed reduced editing in the absence of ADAR, providing a plausible mechanism for the combined effects of hnRNPC and ADAR. This study contributes to our understanding of the control of repetitive element-induced autoinflammation and suggests that patients with hnRNPC-mutated tumors might maximally benefit from ADAR inhibition-based immunotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom